By Maddie Burakoff

Oetzi the Iceman has a new look. Decades after the famous glacier mummy was discovered in the Italian Alps, scientists have dug back into his DNA to paint a better picture of the ancient hunter.

They determined that Oetzi was mostly descended from farmers from present day Turkey, and his head was balder and skin darker than what was initially thought, according to a study published Wednesday in the journal Cell Genomics.

Oetzi, who lived more than 5,000 years ago, was frozen into the ice after he was killed by an arrow to the back. His corpse was preserved as a “natural mummy” until 1991, when hikers found him along with some of his clothing and gear — including a copper ax, a longbow and a bearskin hat. Since then, many researchers have worked to uncover more about the mummy, which is displayed at the South Tyrol Museum of Archaeology in Bolzano, Italy.

An earlier draft of Oetzi’s genome was published in 2012. But ancient DNA research has advanced since then, so scientists decided to take another look at the iceman’s genes, explained study author Johannes Krause, a geneticist at Germany’s Max Planck Institute for Evolutionary Anthropology. They used DNA extracted from the mummy's hip bone.

The updated genome is “providing deeper insights into the history of this mummy,” said Andreas Keller of Germany’s Saarland University. Keller worked on the earlier version but was not involved with the latest study.

Based on the new genome, Oetzi's appearance when he died around age 45 was much like the mummy looks today: It's dark and doesn't have much hair on it, said study author Albert Zink, head of the Institute for Mummy Studies at Eurac Research in Italy. Scientists previously thought the iceman was lighter-skinned and hairier in life, but that his mummified corpse had changed over time.

His genome also showed an increased chance of obesity and diabetes, the researchers reported.

And his ancestry suggests that he lived among an isolated population in the Alps, Zink said. Most Europeans today have a mix of genes from three groups: farmers from Anatolia, hunter-gatherers from the west and herders from the east. But 92% of Oetzi’s ancestry was from just the Anatolian farmers, without much mixing from the other groups.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

Share:
More In Science
Walmart and Kroger Raise At-Home Covid Test Prices
As the need for COVID-19 testing increases, so does the price of the tests themselves. An agreement with The White House and several major companies to sell the tests at a lower cost has now expired, sending prices up as retailers struggle to keep kits on shelves. Dr. Thomas McGinn, executive VP of physician enterprise at Common Spirit Health, joins Cheddar News to discuss.
Emission Surge Puts U.S. Further Off Track from Climate Targets
A new report shows 2021 saw a surge in U.S. greenhouse gas emissions, indicating that the country remains far off track from meeting President Biden's climate change targets. Biden previously pledged to cut the nation's emissions in half by 2030, and now experts warn that immediate action must be taken in order to get the nation back on track. Zeke Hausfather, director of climate and energy at The Breakthrough Institute on U.S. Emissions and Global Temperatures, joins Cheddar News to discuss.
Toyota's Chief Scientist on Importance of Diversifying EV Fleets, Including Hybrid Models
Electric vehicles are quickly becoming an accessible way for consumers to slash emissions as legacy automakers begin to electrify their fleets and world leaders including President Joe Biden push for broad EV adoption. But consumers have concerns about EV range, the availability of charging stations, and more. What if it were both helpful to consumers — and feasible from a climate change standpoint — to keep hybrid models that run on gas on the market? Gill Pratt, CEO of the Toyota Research Institute & Toyota Motor Corporation's Chief Scientist joins Cheddar Climate to discuss his team's research about 'carbon return on investment,' how Toyota is electrifying its fleet, and more.
Major Cold Snap Settles Across Much of the U.S.
It's a painfully cold week across a large portion of the U.S. with more than 185 million Americans experiencing below-freezing temperatures on Monday and 10 million of them dealing with dangerous sub-zero temps.
New Study Shows Chatbots Help Prevent Eating Disorders
Ellen Fitzsimmons-Craft, assistant professor of psychiatry at Washington University School of Medicine, joins Cheddar News to discuss how chatbots can help prevent eating disorders and the research that uncovered these findings.
Why The Human Shoulder Is A Design Disaster
Shoulder injuries are one of the most common orthopedic injuries – and they're also one of the most commonly ignored. But chimpanzees, with whom we share nearly 99% of our DNA, don’t encounter the same issues we do. So why are human shoulders such a design disaster? Well, we can trace the answer back to a very particular moment in our evolution.
Nurses Call For Protection For HealthCare Workers
As the Omicron variant continues to sweep across the country. The US Supreme Court is expected to hear arguments at the end of this week on whether or not the Biden administration can force private companies to vaccinate or test millions of their employees. In addition, the National Nurses United has spearheaded legal action to protect nurses and health care workers, patients, and the public while on the job. President of the National Nurses Union, Zenei Cortez, joined Cheddar to discuss more.
Pear Therapeutics CEO on How Its Apps Work for Conditions Like Addiction
Digital medical care provider Pear Therapeutics rang the closing bell on the Nasdaq Friday and President and CEO Dr. Corey McCann, joined Cheddar to talk about how the company plans to grow the business of software-based therapeutics and how the first FDA authorized prescription digital therapeutics company will go about treating illnesses like insomnia and addiction. "These really are pieces of software. In many cases, they're apps and in the cases of our addiction products, these are based on something called cognitive behavioral therapy or CBT," he said. "These products change the patient's brain circuitry to help them be abstinent, to help them stay in treatment, and that's exactly what we see in randomized clinical trials and that's what we see in the real world." He also addressed the ongoing mental health crises brought on by the pandemic. **copy updated to remove IPO information as Pear Therapeutics went public in December**
Load More